190 related articles for article (PubMed ID: 4015060)
1. [Synergistic effect of rifampicin on hepatotoxicity of isoniazid].
Skakun NP; Shman'ko VV
Antibiot Med Biotekhnol; 1985 Mar; 30(3):185-9. PubMed ID: 4015060
[TBL] [Abstract][Full Text] [Related]
2. [Effect of ethyl alcohol on bile production and lipid peroxidation in tetracycline-induced liver lesions].
Skakun NP; Oleĭnik AN; Shman'ko VV; Koval'chuk NA; Koval'chuk SF
Antibiot Med Biotekhnol; 1985 Feb; 30(2):115-8. PubMed ID: 4039911
[TBL] [Abstract][Full Text] [Related]
3. [Comparative hepatic toxicity of isoniazid, rifampicin and ethambutol].
Skakun NP; Tabachuk OE
Probl Tuberk; 1991; (10):77-9. PubMed ID: 1788241
[TBL] [Abstract][Full Text] [Related]
4. [Hepatotoxic effect of a combination of pyrazinamide with isoniazid and rifampicin].
Slivka IuI; Klimniuk EV; Tabachuk OE
Probl Tuberk; 1989; (4):39-42. PubMed ID: 2734263
[TBL] [Abstract][Full Text] [Related]
5. [Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin (author's transl)].
Poupon RY; Meyniel D; Petit J; Gustot P; Darnis F
Ann Med Interne (Paris); 1979; 130(6-7):371-5. PubMed ID: 496138
[TBL] [Abstract][Full Text] [Related]
6. Hepatotoxicity in rifampin-isoniazid treated patients related to their rate of isoniazid inactivation.
Smith J; Tyrell WF; Gow A; Allan GW; Lees AW
Chest; 1972 Jun; 61(6):587-8. PubMed ID: 5032153
[No Abstract] [Full Text] [Related]
7. [Lipid peroxidation and bile formation in a paracetamol lesion of the liver].
Skakun NP; Shman'ko VV
Farmakol Toksikol; 1984; 47(4):105-8. PubMed ID: 6479308
[TBL] [Abstract][Full Text] [Related]
8. [The comparative action of isoniazid, rifampicin and ethambutol on liver function].
Skakun NP; Tabachuk OE
Eksp Klin Farmakol; 1992; 55(2):45-7. PubMed ID: 1422454
[TBL] [Abstract][Full Text] [Related]
9. Isoniazid-rifampicin induced lipid changes in rats.
Pal R; Rana SV; Vaiphei K; Singh K
Clin Chim Acta; 2008 Mar; 389(1-2):55-60. PubMed ID: 18157944
[TBL] [Abstract][Full Text] [Related]
10. Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy.
Li F; Lu J; Cheng J; Wang L; Matsubara T; Csanaky IL; Klaassen CD; Gonzalez FJ; Ma X
Nat Med; 2013 Apr; 19(4):418-20. PubMed ID: 23475203
[TBL] [Abstract][Full Text] [Related]
11. [Hepatotoxicity of rifampicin and isoniazid in the treatment of tuberculous meningitis (author's transl)].
Frontera Izquierdo P; Unceta Aguirre L; Tomás Vila M; Calvo Rigual F; Pérez Tamarit D
An Esp Pediatr; 1981 Dec; 15(6):549-52. PubMed ID: 7337308
[TBL] [Abstract][Full Text] [Related]
12. [Drug-induced hepatitis during a treatment associating isoniazid and rifampicin].
Jean R; Bonnet H; Pages P; Dumas R; Greze J
Ann Pediatr (Paris); 1972 Apr; 19(4):307-11. PubMed ID: 5075678
[No Abstract] [Full Text] [Related]
13. [Role of isoniazid in hepatotoxicity with the INH-rifampicin combination in tuberculosis in children].
Dieu MJ
J Med Lyon; 1972 Oct; 53(234):1323-4 passim. PubMed ID: 4539047
[No Abstract] [Full Text] [Related]
14. The protective effects of ursodeoxycholic acid on isoniazid plus rifampicin induced liver injury in mice.
Chen X; Xu J; Zhang C; Yu T; Wang H; Zhao M; Duan ZH; Zhang Y; Xu JM; Xu DX
Eur J Pharmacol; 2011 May; 659(1):53-60. PubMed ID: 21419764
[TBL] [Abstract][Full Text] [Related]
15. [Isoniazid-rifampicin: a model for hepatotoxicity and for bibliographic Anglomania].
Toulet J; Viteau JM
Gastroenterol Clin Biol; 1978; 2(8-9):756-7. PubMed ID: 361483
[No Abstract] [Full Text] [Related]
16. Latent tuberculosis in childhood: tolerability of two different therapeutic approaches.
Tersigni C; Venturini E; Cordola C; Piccini P; Bianchi L; Montagnani C; Sollai S; Chiappini E; de Martino M; Galli L
Expert Rev Anti Infect Ther; 2018 Apr; 16(4):359-365. PubMed ID: 29465259
[TBL] [Abstract][Full Text] [Related]
17. Anti tubercular treatment induced hepatotoxicity: does acetylator status matter?
Singh J; Garg PK; Thakur VS; Tandon RK
Indian J Physiol Pharmacol; 1995 Jan; 39(1):43-6. PubMed ID: 7705868
[TBL] [Abstract][Full Text] [Related]
18. Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapy.
Lees AW; Allan GW; Smith J; Tyrrell WF; Fallon RJ
Tubercle; 1971 Sep; 52(3):182-90. PubMed ID: 4255439
[No Abstract] [Full Text] [Related]
19. [Fatal liver cell necrosis following short-term administration of isoniazid and rifampicin to a patient already under treatment with antiepileptics].
Lenders JW; Bartelink AK; van Herwaarden CL; van Haelst UJ; van Tongeren JH
Ned Tijdschr Geneeskd; 1983 Mar; 127(10):420-3. PubMed ID: 6835412
[No Abstract] [Full Text] [Related]
20. Hepatoprotective activity of chitosan against isoniazid and rifampicin-induced toxicity in experimental rats.
Santhosh S; Sini TK; Anandan R; Mathew PT
Eur J Pharmacol; 2007 Oct; 572(1):69-73. PubMed ID: 17612523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
